RECORD #556430
714761859 | EH | 19231427 | | 4423362 | 7/6/2005 12:00:00 AM | CAD , ESRD | | DIS | Admission Date: 7/6/2005 Report Status:
Discharge Date: 3/28/2005
****** FINAL DISCHARGE ORDERS ******
LEGLEITER , JASON 856-28-32-2
Virginia
Service: CAR
DISCHARGE PATIENT ON: 4/17/05 AT 01:00 PM
CONTINGENT UPON Not Applicable
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: WOHLSCHLEGEL , MODESTO VINCE , M.D.
CODE STATUS:
Full code
DISPOSITION: Home
DISCHARGE MEDICATIONS:
ENTERIC COATED ASA 325 MG PO QD
ROCALTROL ( CALCITRIOL ) 0.25 MCG PO QD
PHOSLO ( CALCIUM ACETATE ( 1 TABLET=667 MG ) )
1 , 334 MG PO TID
LOPRESSOR ( METOPROLOL TARTRATE ) 25 MG PO BID
Starting Today ( 0/17 ) HOLD IF: sbp&lt;100 , hr&lt;55
Food/Drug Interaction Instruction
Take consistently with meals or on empty stomach.
NORVASC ( AMLODIPINE ) 10 MG PO QD
Food/Drug Interaction Instruction
Avoid grapefruit unless MD instructs otherwise.
IMDUR ( ISOSORBIDE MONONITRATE ( SR ) ) 60 MG PO QD
HOLD IF: sbp&lt;100 , hr&lt;55 Food/Drug Interaction Instruction
Give on an empty stomach ( give 1hr before or 2hr after
food )
Alert overridden: Override added on 10/0/05 by
LINDSAY , ERIN R. , M.D.
on order for IMDUR PO ( ref # 474528543 )
Pt. has a PROBABLE allergy to NITROGLYCERIN I.V.; reaction
is syncope. Reason for override: takes as outpt
LIPITOR ( ATORVASTATIN ) 80 MG PO QD
Override Notice: Override added on 10/0/05 by
LIMOLI , SAMMIE E. , M.D.
on order for NEPHRO-VIT RX PO ( ref # 016568843 )
POTENTIALLY SERIOUS INTERACTION: ATORVASTATIN CALCIUM &amp;
NIACIN , VIT. B-3 Reason for override: aware
NEPHRO-VIT RX 1 TAB PO QD
Alert overridden: Override added on 10/0/05 by
MCGHANEY , IVORY R. , M.D.
POTENTIALLY SERIOUS INTERACTION: ATORVASTATIN CALCIUM &amp;
NIACIN , VIT. B-3 Reason for override: aware
PLAVIX ( CLOPIDOGREL ) 75 MG PO QD
Starting Tomorrow ( 4/13 )
PROTONIX ( PANTOPRAZOLE ) 40 MG PO QD
GLIPIZIDE 7.5 MG PO QD
POTASSIUM CHLORIDE SLOW REL. ( KCL SLOW RELEASE )
20 MEQ PO QD As per AH Potassium Chloride Policy:
each 20 mEq dose to be given with 4 oz of fluid
DIET: House / Adv. as tol. / NAS / ADA 2500 cals/day / Low saturated fat
low cholesterol / Renal diet (FDI)
ACTIVITY: Walking as tolerated
FOLLOW UP APPOINTMENT( S ):
Dialysis Saturday 3 of April scheduled ,
Dr. Precella (Cardiology ) 3 of October at 11:15 AM at SMH Wood scheduled ,
ALLERGY: NITROGLYCERIN I.V.
ADMIT DIAGNOSIS:
Chest pain
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
CAD , ESRD
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
S/P CABG H/O POLYPECTOMY '92 H/O
NEPHROLITHIASIS h/o chronic renal insufficiency ( H/O chronic renal
dysfunction ) gout ( gout ) h/o gastritis/duodenitis ( H/O
gastritis ) h/o hiatal hernia ( H/O hiatal hernia ) h/o GERD ( H/O
esophageal reflux ) h/o hypercholesterolemia ( H/O elevated
cholesterol ) htn ( hypertension ) CAD s/p cabg
OPERATIONS AND PROCEDURES:
Cardiac catheterization
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
None
BRIEF RESUME OF HOSPITAL COURSE:
CC: chest pain
HPI: 76 year old man with CAD s/p CABG , ESRD , previously stable angina
with +MIBI in 2004 , gib , Fe-def anemia , who was admitted for increasing
angina and worsening MIBI. During hospitalization he underwent cardiac
catheterization with bare metal stent placement and began hemodialysis.
-----------
STUDIES:
1/8 Echo EF 50% , dil LV , mild conc LVH , no WMA , + paradoxical wall
motion
7/25 MIBI: med sized defect of severe intensity
in med and basal ant and anterolat wall with mod reversibility
1/22 CATH: Only LIMA to LAD patent of grafts , RCA stented with bare
metal
------------
EKG: NSR , 1AVG , LBBB
------------
Admission PE: Vitals 96.6 , 62 , 166/70 , 20 , 98% on RA
Gen: NAD , pale
Heart: JVP to ear , RRR with systolic murmur at RUSB
Lungs: clear
Abd: soft , NTND
Ext: Bouchard's nodes , 2+ DPs , palp thrill in LUE AV fistula
Groin: w/o hematoma.
-----------
Hospital Course by System:
1. CV: I: Patient underwent cardiac cath on 4 of October which revealed 100%
occlusion of LAD , 100% occlusion of Proximal LCx , Rt LV-BR mid 70% ,
LIMA- LAD patent. Stented RCA with bare metal stent. TPW placed , then
removed. Patient was treated with ASA , plavix , statin , beta-blocker. AM
lipid panel was drawn and was pending at time of d/c. Patient will
follow-up with cardiology as outpatient.
P: history of HTN , continued on beta-blocker , ccb and nitrate. Held lasix
since started dialysis.
R: Patient was monitored on telemetry with no active issues
2. Renal: Patient was started on dialysis during hospitalization. He is
to attend dialysis on 28 of April
3. Endo: Kept on ISS , changed back to home glipizide prior to discharge.
4. Heme: Anemic , Fe def , continued niferex per home regimen
5. FEN: Electrolytes were monitored and replaced prn. Maintained on
phoslo , nephrovite , calcitriol. Renal , cardiac diet
6. Ppx: sc hep
7. Dispo: Patient was discharged to home in stable condition.
He is to follow-up with dialysis on Friday and Dr. Mays in cardiology
on 7 of August at 11:15 AM
ADDITIONAL COMMENTS: Please take all prescribed medications and attend dialysis on Friday as
well as cardiology follow-up as scheduled. Return to hospital if you
develop chest pain , shortness of breath , nausea , vomiting , or any other
symptoms that you find concerning.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
No dictated summary
ENTERED BY: HARRALSON , OTHA C. , M.D. , PH.D. ( EV44 ) 4/17/05 @ 11
****** END OF DISCHARGE ORDERS ******
[report_end]
